Evidence map›Paper›PMID 41816040›Full record

ArticleQuantitative imaging in medicine and surgery2026

Progressive iron deposition and widespread neural dysfunction in Parkinson's disease: a multimodal MRI study.

Shuo Liu, Xinhui Wang, Wei Wei, Yan Bai, Yu Shen, E Mark Haacke, Bo Wu, Hongxia Xin, Kaixin Li, Meiyun Wang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shuo LiuDepartment of Medical Imaging, Xinxiang Medical University & Henan Provincial People's Hospital, Zhengzhou, China.
Xinhui WangDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China.
Wei WeiDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China.
Yan BaiDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China.
Yu ShenDepartment of Medical Imaging, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China.
E Mark HaackeDepartment of Radiology, Wayne State University School of Medicine, Detroit, MI, USA.
Bo WuShanghai Zhu Yan Medical Technology Ltd., Shanghai, China.
Hongxia XinDepartment of Medical Equipment, Henan Provincial People's Hospital, Zhengzhou, China.
Kaixin LiMR Research Collaboration, Siemens Healthineers Ltd., Beijing, China.
Meiyun WangDepartment of Medical Imaging, Xinxiang Medical University & Henan Provincial People's Hospital, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, yet its stage-dependent neurobiological mechanisms remain incompletely understood. Multimodal magnetic resonance imaging (MRI) offers a noninvasive approach to investigate both functional and structural alterations across disease stages. Therefore, this study aimed to characterize stage-dependent functional and iron-related brain alterations in PD using multimodal MRI and to explore their associations with motor severity. Methods: We enrolled 104 PD patients, stratified into early-stage (n=49) and advanced-stage (n=55) based on Hoehn and Yahr (H&Y) score, along with 53 age- and sex- matched healthy controls. Quantitative susceptibility mapping (QSM) quantified iron deposition in the substantia nigra (SN) and globus pallidus (GP), while resting-state functional magnetic resonance imaging (rs-fMRI) was used to assess functional alterations using regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF). Group comparisons were conducted using one-way analysis of variance (ANOVA) with post-hoc tests, and voxel-wise analyses were corrected using cluster-level false discovery rate (FDR, P<0.05). Correlation analyses were performed to evaluate associations between imaging metrics and Unified Parkinson's Disease Rating Scale part III (UPDRS-III) motor scores. Results: Compared with healthy controls, both early and advanced-stage PD patients showed significantly increased iron deposition in the bilateral SN and GP (all P<0.05), with higher QSM values in advanced-stage PD than in early-stage PD (all P<0.01). Iron deposition in these regions was positively correlated with motor severity assessed by UPDRS-III scores (all P<0.001). Early-stage PD primarily exhibited abnormal fALFF and ReHo in visual-related regions, whereas advanced-stage PD showed more widespread involvement of the basal ganglia-thalamocortical motor circuit, frontoparietal regions, and limbic structures. Functional alterations in motor-related regions were significantly associated with UPDRS-III scores (all P<0.001), while ReHo changes in limbic regions were correlated with cognitive performance (Mini-Mental State Examination, MMSE; P<0.001). Conclusions: Building on established evidence that PD involves progressive iron deposition in the SN and GP and widespread neural network dysfunction, our multimodal MRI findings demonstrate that integrating ReHo, fALFF, and QSM provides a framework for characterizing stage-specific pathophysiological changes and support their potential as biomarkers for early diagnosis, disease staging, and therapeutic development.

Indexed as

Parkinson’s disease (PD)quantitative susceptibility mapping (QSM)resting-state functional magnetic resonance imaging (rs-fMRI)strategically acquired gradient echo

Identifiers

PMID41816040
PMCPMC12971341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.